Inventor
BONE WILHELM
DE20 patents
⚠️ This page may combine multiple inventors who share the name “BONE WILHELM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
Bayer Pharma AG
10 patentsUS9549932B2Jan 24, 2017
2-(morpholin-4-yl)-1,7-naphthyridines
Bayer Pharma AG26 citations93
US9993484B2Jun 12, 2018
2-(morpholin-4-yl)-1,7-naphthyridines
Bayer Pharma AG4 citations83
US11529356B2Dec 20, 2022
2-(morpholin-4-yl)-1,7-naphthyridines
Bayer Pharma AG1 citations72
US10772893B2Sep 15, 2020
2-(morpholin-4-yl)-1,7-naphthyridines
Bayer Pharma AG2 citations72
US9765058B2Sep 19, 2017
Substituted benzylpyrazoles
Bayer Pharma AG3 citations71
US9745285B2Aug 29, 2017
Heteroaryl substituted pyrazoles
Bayer Pharma AG3 citations71
US9682974B2Jun 20, 2017
Heteroaryl substituted pyrazoles
Bayer Pharma AG4 citations71
US10350206B2Jul 16, 2019
Benzyl substituted indazoles as BUB1 inhibitors
Bayer Pharma AG1 citations61
US10894784B2Jan 19, 2021
Heteroarylbenzimidazole compounds
Bayer Pharma AG0 citations48
US10428044B2Oct 1, 2019
3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones
Bayer Pharma AG0 citations39
KLAR ULRICH
4 patentsUS9206219B2Dec 8, 2015
17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and the use thereof for treating diseases
KLAR ULRICH0 citations51
US9096640B2Aug 4, 2015
17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-methylene oxyalkylene aryl derivatives, process for preparation thereof, and use thereof for treatment of diseases
KLAR ULRICH0 citations51
US9156877B2Oct 13, 2015
17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzylidene derivatives, methods for the production thereof and use thereof for treating diseases
KLAR ULRICH0 citations40
US9102701B2Aug 11, 2015
17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-ethynylphenyl derivatives, methods for the production thereof and use thereof for treating diseases
KLAR ULRICH0 citations40
SCHWEDE WOLFGANG
3 patentsUS8278469B2Oct 2, 2012
17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases
SCHWEDE WOLFGANG7 citations81
US9109004B2Aug 18, 2015
Progesterone receptor antagonists
SCHWEDE WOLFGANG2 citations60
US9085603B2Jul 21, 2015
Progesterone receptor antagonists
SCHWEDE WOLFGANG3 citations60
BAYER IP GMBH
2 patentsUS10155004B2Dec 18, 2018
17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases
BAYER IP GMBH4 citations82
US9717739B2Aug 1, 2017
17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases
BAYER IP GMBH2 citations71